• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » U.S. companies starting to see relief from pains of strong dollar

U.S. companies starting to see relief from pains of strong dollar

May 2, 2016 By Brad Perriello

dollar(Reuters) — The sluggish U.S. economy is proving to be a relief for U.S.-based companies struggling under the weight of the strong dollar and could lead to more positive earnings surprises in the weeks ahead.

Companies including Whirlpool (NYSE:WHR), Johnson & Johnson (NYSE:JNJ) and Xerox (NYSE:XRX) have told investors over the last 2 weeks that they see the pain from the dollar’s 2-year rally easing, allowing them in some cases to beat earnings estimates and raise their outlooks for the rest of the year.

Less well-known companies are benefiting, too: Insect repellent company Rollins (NYSE:ROL) said the weaker dollar was a key reason why it beat estimates when it announced its quarterly results April 27, while medical supply maker C.R. Bard (NYSE:BCR) cited the weakening of the dollar when it announced that it was raising its guidance for the year.

“We think we’ve seen an inflection point where for the balance of the year there should less of a drag from currency,” said Phil Orlando, equity strategist at Federated Investors.

The dollar has backed off from 12-year highs it reached in November against a basket of other major currencies, as U.S. gross domestic product numbers flatlined, leaving many investors to assume the Federal Reserve will delay raising interest rates. The dollar hit an 11-month low April 29.

A weaker dollar helps U.S. companies by making their products cheaper overseas, while also boosting the value of revenues earned in local currencies when translated back into dollars. Most large companies hedge at least part of their foreign revenues, so the effect of currency fluctuations often translates to less than 5% of total earnings, Orlando said.

Yet at a time when many companies are struggling to post any year-over-year earnings growth, unexpected relief from the strong dollar blues could be enough for them to beat estimates and send shares higher.

Johnson & Johnson, for instance, said the strong dollar took a 3.3% slice out of global sales in its 1st quarter, half of the impact from the quarter before. Its shares rose 2.7% after it reported its results, hitting a record high.

‘Easier from here on out’

Overall, 72% of U.S. multinational companies – those which would see the largest impact from currency fluctuations – have beat earnings per share estimates this quarter, in large part because of the dollar’s decline, according to Thomas Lee, managing partner at Fundstrat Global Advisors.

In a sign that the dollar’s slide should continue to help for the remainder of the year, analysts have raised their earnings per share estimates for 57% of multinationals, by an average of nearly 1%, he said.

The dollar’s retreat comes on the heels of the 4th quarter of 2015, when currency translation took $33.94 billion out of North American company revenues, the worst negative impact in nearly 5 years, according to research firm FireApps.

Fund managers, meanwhile, say that the weaker dollar will help stabilize commodity prices, which are often priced in dollars, helping both energy company earnings and overall investor sentiment.

With lower currency costs and an easing of fears that sustained oil prices below $30 a barrel will lead to deep layoffs among energy companies, a “weaker dollar makes things easier from here on out,” said Mike Balkin, a portfolio manager at William Blair.

Filed Under: Business/Financial News, Wall Street Beat Tagged With: C.R. Bard, Johnson and Johnson

More recent news

  • AdvaMed calls for medtech tariff exemptions at Senate hearing
  • GE HealthCare, Raydiant Oximetry partner on fetal oxygen saturation tech
  • Terumo Neuro launches new stroke catheter in the U.S.
  • EnVVeno has first-in-human heart valve data, expects FDA decision this year
  • Axoft makes Fleuron BCI material available for purchase, inks license deal with Stanford

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy